Kennedy Capital Management’s NuVasive, Inc. NUVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-265,495
| Closed | -$11M | – | 726 |
|
|
2023
Q2 | $11M | Buy |
265,495
+95,477
| +56% | +$3.92M | 0.26% | 122 |
|
|
2023
Q1 | $7.02M | Sell |
170,018
-9,153
| -5% | -$392K | 0.21% | 173 |
|
|
2022
Q4 | $7.39M | Sell |
179,171
-1,013
| -0.6% | -$41K | 0.21% | 162 |
|
|
2022
Q3 | $7.89M | Buy |
180,184
+126,392
| +235% | +$6.13M | 0.23% | 144 |
|
|
2022
Q2 | $2.64M | Buy |
53,792
+2,651
| +5% | +$142K | 0.07% | 385 |
|
|
2022
Q1 | $2.9M | Sell |
51,141
-510
| -1% | -$27.1K | 0.07% | 395 |
|
|
2021
Q4 | $2.71M | Sell |
51,651
-1,811
| -3% | -$98.4K | 0.06% | 420 |
|
|
2021
Q3 | $3.2M | Buy |
53,462
+643
| +1% | +$39.6K | 0.07% | 421 |
|
|
2021
Q2 | $3.58M | Sell |
52,819
-123,147
| -70% | -$8.41M | 0.08% | 417 |
|
|
2021
Q1 | $11.5M | Buy |
175,966
+6,724
| +4% | +$403K | 0.23% | 142 |
|
|
2020
Q4 | $9.53M | Buy |
+169,242
| New | +$8.32M | 0.22% | 152 |
|
|
2016
Q4 | – | Sell |
-24,934
| Closed | -$1.66M | – | 777 |
|
|
2016
Q3 | $1.66M | Sell |
24,934
-9,309
| -27% | -$593K | 0.03% | 606 |
|
|
2016
Q2 | $2.04M | Sell |
34,243
-367
| -1% | -$19.8K | 0.04% | 564 |
|
|
2016
Q1 | $1.68M | Buy |
34,610
+891
| +3% | +$40.4K | 0.03% | 611 |
|
|
2015
Q4 | $1.82M | Buy |
+33,719
| New | +$1.72M | 0.04% | 584 |
|
Other funds holding NUVA
Kennedy Capital Management's NUVA Position: Q3 2023 in Review
Kennedy Capital Management sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 265,495 shares — an estimated $11M sold.
Kennedy Capital Management first reported a position in NUVA in Q4 2015 and held it in 15 quarters. The position peaked at $11.5M in Q1 2021. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.
- Kennedy Capital Management reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
- Kennedy Capital Management sold 265,495 NuVasive, Inc. shares in Q3 2023, an estimated $11M.
- Kennedy Capital Management first reported a position in NuVasive, Inc. in Q4 2015 and held it in 15 quarters.
- Kennedy Capital Management's NuVasive, Inc. position peaked at $11.5M in Q1 2021.
- 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.
Based on Kennedy Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.